Singapore's NUSX Expands to Munich and Shanghai, Debuts AI Patent Platform Nova

·
Listen to this article~4 min

NUS Enterprise rebrands as NUSX, opens outposts in Munich and Shanghai, and launches Nova, an AI platform that turns patents into partnerships. Here's what it means for global innovation.

### NUSX: A New Identity for Global Innovation NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), has rebranded as NUSX. This isn't just a name change—it's a bold statement. NUSX is evolving into a full-fledged venture-building and IP commercialization platform. The goal? To bring together research, talent, industry, capital, and global markets to turn discoveries into scalable ventures. ### Outposts in Munich and Shanghai: Connecting East and West Building on its first outpost in Silicon Valley (launched in July 2026 at Playground Global's The Studio), NUSX is now planting flags in Munich and Shanghai. The Munich outpost, established through a partnership with UnternehmerTUM, will serve as a gateway to Europe's leading tech ecosystem. The Shanghai outpost, planned for Q4 2026, will open doors to China's dynamic market. These outposts aren't just offices—they're bridges. They give NUS deep tech ventures early access to overseas markets, partners, investors, and customers across the US, Europe, and China. And the insights gained abroad flow back to Singapore, strengthening the entire innovation ecosystem. ### The Singapore-Munich Partnership: A Three-Pronged Approach The collaboration between NUSX and UnternehmerTUM, announced at A5X, focuses on three key areas: - **Reciprocal outposts:** Physical spaces that foster exchange between Singapore and Munich. - **Investment:** Connecting startups with capital to scale globally. - **Talent development:** Nurturing the next generation of innovators. The initial focus? Biotech, AI, and semiconductors—fields where both regions excel. ### Nova: AI That Turns Patents into Partnerships Here's a startling fact: 70% to 80% of university patents worldwide are never licensed. Why? Because finding the right commercial partner is like searching for a needle in a haystack. Researchers know their work's scientific value but often lack visibility into industry problems it could solve or companies that might benefit. Enter Nova, an AI-powered engine developed by NUSX and Zima Labs. Nova analyzes a granted patent in minutes, assesses its licensing potential against live market evidence, ranks potential licensees based on complementary fit, and even drafts tailored proposals. It also flags limitations. How does it work? Nova draws on over 20,000 NUS patents and invention disclosures, 9,000 research projects, and 11,000 inventors. It connects this internal data with external intelligence on companies, investors, industry needs, and market activities. Through AI-powered search and automated workflows, it surfaces potential partners, licensing pathways, co-development opportunities, and even potential investors and team members. Every recommendation is backed by evidence, enabling commercialization managers to do in minutes what used to take weeks. > "Nova is like having a superpower for tech transfer," says a commercialization manager. "It finds the right partner and gives us the evidence to back it up." ### What This Means for the Global Startup Scene For European startups and innovators, NUSX's expansion means new opportunities for collaboration, investment, and market access. The Munich outpost, in particular, will strengthen ties between Singapore and Europe's thriving tech hubs. And Nova could revolutionize how universities commercialize research worldwide. As NUSX continues to grow, one thing is clear: the future of innovation is global, and NUSX is building the infrastructure to make it happen.